These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37013589)

  • 1. Does adjuvant hepatic artery infusion chemotherapy improve patient outcomes for hepatocellular carcinoma following liver resection? A meta-analysis.
    Hu L; Zheng Y; Lin J; Shi X; Wang A
    World J Surg Oncol; 2023 Apr; 21(1):121. PubMed ID: 37013589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison Between Portal Vein Perfusion Chemotherapy and Neoadjuvant Hepatic Arterial Infusion Chemotherapy for Resectable Intermediate to Advanced Stage Hepatocellular Carcinoma.
    Pan Y; Mei J; Chen J; Zhang D; Wang J; Wang X; Yi M; Zhou Z; Zhang Y; Chen M; Guo R; Xu L
    Ann Surg Oncol; 2022 Mar; 29(3):2016-2029. PubMed ID: 34637058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis.
    Liu M; Shi J; Mou T; Wang Y; Wu Z; Shen A
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1277-1287. PubMed ID: 32052876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Resection for Hepatocellular Carcinoma with Tumor Thrombus in the Major Portal Vein.
    Kojima H; Hatano E; Taura K; Seo S; Yasuchika K; Uemoto S
    Dig Surg; 2015; 32(6):413-20. PubMed ID: 26316188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment.
    Hsiao JH; Tsai CC; Liang TJ; Chiang CL; Liang HL; Chen IS; Chen YC; Chang PM; Chou NH; Wang BW
    Int J Surg; 2017 Sep; 45():35-41. PubMed ID: 28728985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of different adjuvant therapy regimen efficacies in patients with high risk of recurrence after radical resection of hepatocellular carcinoma.
    Feng X; Feng GY; Tao J; Ao YP; Wu XH; Qi SG; Shi ZR
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10505-10518. PubMed ID: 37284841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Hepatic Arterial Infusion Chemotherapy in the Treatment of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Li S; Xu J; Zhang H; Hong J; Si Y; Yang T; He Y; Ng DM; Zheng D
    Chemotherapy; 2021; 66(4):124-133. PubMed ID: 34515082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Resection Followed by Hepatic Arterial Infusion Chemotherapy for Hepatocellular Carcinoma with Intrahepatic Dissemination.
    Kuramoto K; Beppu T; Nitta H; Imai K; Masuda T; Miyata T; Koga Y; Kitano Y; Kaida T; Nakagawa S; Okabe H; Hayashi H; Hashimoto D; Yamashita YI; Chikamoto A; Kikuchi K; Baba H
    Anticancer Res; 2018 Jan; 38(1):525-531. PubMed ID: 29277819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Hatano E; Uemoto S; Yamaue H; Yamamoto M;
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):395-402. PubMed ID: 30091239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hepatic arterial infusion chemotherapy in the treatment of hepatocellular carcinoma: A meta-analysis.
    Long GB; Xiao CW; Zhao XY; Zhang J; Li X
    Medicine (Baltimore); 2020 Jun; 99(26):e20745. PubMed ID: 32590750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.
    Chen ZH; Zhang XP; Zhou TF; Wang K; Wang H; Chai ZT; Shi J; Guo WX; Cheng SQ
    Eur J Surg Oncol; 2019 Nov; 45(11):2188-2196. PubMed ID: 31256949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report.
    Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H
    World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant hepatic arterial infusion chemotherapy in patients with resected hepatocellular carcinoma with microvascular invasion.
    Tsilimigras DI; Pawlik TM
    Chin Clin Oncol; 2024 Feb; 13(1):16. PubMed ID: 37953245
    [No Abstract]   [Full Text] [Related]  

  • 14. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class A.
    Lee BH; Lee DS; Cho CW; Yun SS
    World J Surg Oncol; 2019 Aug; 17(1):143. PubMed ID: 31416447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).
    Lyu N; Wang X; Li JB; Lai JF; Chen QF; Li SL; Deng HJ; He M; Mu LW; Zhao M
    J Clin Oncol; 2022 Feb; 40(5):468-480. PubMed ID: 34905388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant hepatic arterial infusion chemotherapy after hepatic resection of hepatocellular carcinoma with macroscopic vascular invasion.
    Nitta H; Beppu T; Imai K; Hayashi H; Chikamoto A; Baba H
    World J Surg; 2013 May; 37(5):1034-42. PubMed ID: 23435678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases: a systematic review and meta-analysis.
    Buisman FE; Filipe WF; Galjart B; Grünhagen DJ; Homs MYV; Moelker A; Verhoef C; Groot Koerkamp B
    HPB (Oxford); 2022 Mar; 24(3):299-308. PubMed ID: 34895829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
    Moran A; Ramos LF; Picado O; Pendola F; Sleeman D; Dudeja V; Merchant N; Yakoub D
    J Surg Oncol; 2019 Mar; 119(4):455-463. PubMed ID: 30575028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma.
    Ke Q; Wang L; Wu W; Huang X; Li L; Liu J; Guo W
    Front Oncol; 2021; 11():720079. PubMed ID: 35004268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.